The largest database of trusted experimental protocols

11 protocols using god pap

1

Comprehensive Metabolic Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose was measured with the glucose-oxidase GOD-PAP method (Roche Diagnostics, Mannheim, Germany). Plasma levels of triglycerides, uric acid, and transaminases (aspartate aminotransferase-GOT and alanine aminotransferase-GPT) were assayed by commercial (enzymatic-colorimetric) kits (Wiener Lab., Rosario, Santa Fe, Argentina). Circulating immunoreactive insulin was determined by a previously described specific radioimmunoassay [38 (link)].
Glycemia and insulin values were used to estimate peripheral IR by homeostasis model assessment of insulin resistance (HOMA-IR) (insulin × glycemia/22.5) [39 (link)] and β-cell function by HOMA-β [(20 × insulin/glycemia) − 3.5]. Liver insulin sensitivity index (LISI) was calculated by the following formula: k/(fasting plasma insulin) × fasting glycemia, where k = 22.5 × 18 (insulin/glycemia) [40 (link)]. Insulin and glycemia were expressed as μUI/mL and mM, respectively.
+ Open protocol
+ Expand
2

Assessing Metabolic Biomarkers and Insulin Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose, triglycerides and non-esterified free fatty acids were assayed by enzymatic colorimetric tests (GOD-PAP, LPL/GOP-Trinder, Roche Diagnostics, Basil, Switzerland and HR Series NEFA-HR, Wako Diagnostics, Neuss, Germany). Plasma levels of insulin were measured using a Milliplex MADPK-71K adipokine kit (Merck-Millipore, Burlington, MA, USA) according to the manufacturer’s instructions. For estimation of insulin resistance, HOMA index was calculated as HOMA-IR = (FPG × FPI)/2430, where FPI was in microunits per milliliter and FPG in milligram per deciliter, as previously described [35 (link)].
+ Open protocol
+ Expand
3

Metabolic Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose and triglycerides were determined by enzymatic colorimetric test (GOD-PAP and LPL/GOP-Trinder, Roche Diagnostics, Barcelona, Spain). Plasma levels of insulin were measured using a Milliplex MADPK-71K adipokine kit according to manufacturer´s description (Millipore). For estimation of insulin resistance HOMA index was calculated as previously described [26 (link)]. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzymatic activities were measured using an commercial kit (GPT/ALT and GOT/AST, Sinreact, Spain).
+ Open protocol
+ Expand
4

Metabolic Biomarker Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma glucose concentration was measured colorimetrically (glucose oxidase-phenol and 4
aminophenazone (GOD-PAP) method; Roche Diagnostics) and analysed using a micro plate
imaging system (Bio-Rad Laboratories, Inc.). Insulin concentration was measured using
ELISA (DRG) according to the manufacturer’s protocol. Homoeostasis model assessment of
insulin resistance as calculated from fasting plasma glucose and insulin concentrations
(glucose (mmol/l)×insulin (pmol/l)/22·5) as an indirect measure of insulin sensitivity.
Total cholesterol, HDL-cholesterol, LDL-cholesterol, VLDL-cholesterol and TAG
concentrations were determined colorimetrically after enzymatic conversion using a Roche
Hitachi 717 analyzer (Reinier de Graaf Laboratory).
+ Open protocol
+ Expand
5

Plasma Metabolic and Hormonal Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glycemia was measured by the glucose-oxidase GOD-PAP method (Roche Diagnostics, Mannheim, Germany) and plasma concentrations of triglycerides, uric acid, and transaminases aspartate aminotransferase (GOT) and alanine aminotransferase (GPT) were determined by commercial (enzymatic-colorimetric) assays (Wiener Lab, Argentina). Peripheral immunoreactive insulin [13 (link)], leptin, and corticosterone [16 (link)] levels were determined by previously described specific radioimmunoassays. Lipid peroxidation was estimated by measuring TBARS (thiobarbituric acid-reactive substance) [20 (link)]. The amount of TBARS formed was calculated by extinction coefficient of the MDA (malondialdehyde)-TBA complex of 1.56 × 105 (mol/L)−1·cm−1 and expressed as pmol of MDA/mg of plasma protein per mL of plasma, measured with the Bio-Rad Protein Assay kit.
Fasting glycemia and insulin values were used to estimate peripheral insulin resistance by homeostasis model assessment-insulin resistance (HOMA-IR) [insulin (μUI/mL) × glycemia (mM)/22.5]. Liver insulin sensitivity index (LISI) was calculated with the following formula: k/(fasting plasma insulin) × fasting glycemia, where k = 22.5 × 18 [21 (link)].
+ Open protocol
+ Expand
6

Metabolic Responses to Mixed Meal

Check if the same lab product or an alternative is used in the 5 most similar protocols
After an overnight fast, participants were given a 3-h mixed meal challenge (500 kcal, 60% CHO, 20% fat, and 20% protein). Blood samples were collected at 0, 30, 60, 90, 120, and 180 min for plasma glucose, insulin, proinsulin, triglycerides, and glucagon measurements. Glucose was assessed using a glucose-oxidase method (GOD/PAP, Roche Diagnostics, Germany). Insulin was assessed by a chemiluminescent method (Roche Diagnostics, Germany). Proinsulin and glucagon were assessed by a double-antibody radioimmunoassay (Linco Research, USA). Free fatty acid fasting levels were assessed by a colorimetric assay (Wako, USA). Subjects were instructed to refrain from physical exercise, alcohol, and caffeine intake 24 h prior to the test.
+ Open protocol
+ Expand
7

Biochemical Markers of Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose ((GOD-PAP); Roche Diagnostics, Barcelona, Spain), triacylglycerides ((LPL- GPO); Roche Diagnostics), cholesterol ((CHOD-POD); Spinreact, Girona, Spain), glycerol (GPO-Trinder, Sigma Diagnostic, Madrid, Spain) and NEFA ((ACS-ACOD); Wako Chemicals, Neuss, Germany) levels were determined by enzymatic colorimetric tests. Plasma insulin measurement (Mercodia, Uppsala, Sweden) was determined using immunoassay kits. The HOMA-IR insulin resistance index and QUICKI insulin sensitivity index were calculated as previously described [33 (link)].
+ Open protocol
+ Expand
8

Hormonal Profile Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood samples were obtained from the antecubital area by phlebotomy between the hours of 08:00 and 09:00 following 10-12 h of fasting. After these samples were allowed to clot, they were centrifuged for 10 minutes at 3000 g. The sera were separated and stored at -70°C until the analysis.
Plasma glucose levels were measured by enzymatic colorimetric assay (GOD-PAP, Roche Diagnostics, Mannheim). Plasma zinc and copper levels were measured by atomic absorption spectrophotometry (ContrAA700, Analytik Jena AG, Germany) with an intra-assay CV of 2.4% and an inter-assay CV of 3.1%. Electrochemoluminescence immunoassay was used to measure serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin and 17-hydroxy-progesterone (Roche Elecsys 1010/2010, Roche Diagnostics, Mannheim, Germany). The serum concentrations of dehidroepiandrosterone sulphate (DHEAS), thyroid stimulating hormone (TSH), total testosterone, free testosterone and insulin were measured by radioimmunoassay (DSL Diagnostic Systems Laboratories, USA). The intra-assay CVs were 5.3%, 3.8%, 7.8%, 6.2%, 5.0%, 9.6%, 10.0%, 9.6%, 9.7% and 8.2% whereas the inter-assay CVs were 1.8%, 1.5%, 10.0%, 5.7%, 4.1%, 9.3%, 7.8%, 6.6%, 6.2% and 7.4% for FSH, LH, estradiol, prolactin, 17-hydroxy-progesterone, DHEAS, TSH, total testosterone, free testosterone and insulin respectively.
+ Open protocol
+ Expand
9

Plasma Biochemical Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial enzymatic tests were used to determine in plasma samples: glucose (GOD-PAP, Roche Diagnostics, Spain), triacylglycerides (LPL/GPO-Trinder Roche Diagnostics, Spain), glycerol (GPO-Trinder, Sigma Diagnostic, Spain), cholesterol (Menarini, Italy), non-esterified fatty acids (NEFA) (ACS-ACOD, Wako Chemicals GmbH, Germany) and ketone bodies (Wako Chemicals GmbH, Germany). Plasma insulin was determined with a specific EIA kit for rats (Mercodia, Denmark). Corticosterone, leptin and adiponectin were determined in plasma samples by X-Map Technology (Bioplex 100X, Spain) using the "rat stress hormone" RSH69K and "rat adipocyte" RADPCYT-82 panels (Millipore, Spain).
+ Open protocol
+ Expand
10

Diabetic Rat Model and Dgkh Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Central South University Department of Laboratory Animals provided healthy male Sprague–Dawley (SD) rats (180–200 g) that had been reared under specific-pathogen-free conditions. After 1 week of adaptive feeding, the rats were randomly separated into diabetes and normal control groups. STZ (55 mg/kg, Sigma, St. Louis, MO, USA) was administered intraperitoneally to SD rats in the diabetic group to cause diabetes [59 ]. The glucose oxidase method was used to measure fasting plasma glucose levels (GOD-PAP; Boehringer Mannheim). Following 3 days of STZ injection, rats with blood glucose levels greater than 16.7 mmol/l were chosen for follow-up investigations [60 (link)]. The normal control and diabetic groups were divided into four groups at random for ventricular stereotaxic injection after the induction of diabetes for 10 weeks: (1) control rats stereotaxically injected with negative adenovirus (CON + AD-NULL); (2) diabetic rats stereotaxically injected with negative adenovirus (DM + AD-NULL); (3) diabetic rats stereotaxically injected with overexpression of Dgkh adenovirus (DM + AD-Dgkh); and (4) control rats stereotaxically injected with overexpression of Dgkh adenovirus (CON + AD-Dgkh). Behavioral experiments were performed at week 12, and the rats were sacrificed after the behavioral experiments had been completed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!